Paper38947111
Cancer to Cataracts: The Mechanistic Impact of Aldo-Keto Reductases in Chronic Diseases.
Shanbhag AP and 1 other. Yale J Biol Med, 2024. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Cancer to Cataracts: The Mechanistic Impact of Aldo-Keto Reductases in Chronic Diseases. Papers, record 38947111. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38947111
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aldo-Keto Reductases | Major topic |
| Cataract | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Chronic Disease |
Source PubMed
References115
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21276783 | Activities of aldo-keto reductase 1 enzymes on two inhaled corticosteroids: implications for the pharmacological effects of inhaled corticosteroids. | Chem Biol Interact | 2011 | https://conductscience.org/library/papers/21276783 | PubMed |
| 2 | 31271032 | Thymol Mediates Bactericidal Activity against Staphylococcus aureus by Targeting an Aldo-Keto Reductase and Consequent Depletion of NADPH. | J Agric Food Chem | 2019 | https://conductscience.org/library/papers/31271032 | PubMed |
| 3 | 12604219 | Aldo-keto reductases as modulators of stress response. | Chem Biol Interact | 2003 | https://conductscience.org/library/papers/12604219 | PubMed |
| 4 | 25304492 | The aldo-keto reductases (AKRs): Overview. | Chem Biol Interact | 2015 | https://conductscience.org/library/papers/25304492 | PubMed |
| 5 | 34884615 | Cytochrome P450 Enzymes and Drug Metabolism in Humans. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34884615 | PubMed |
| 6 | 21255593 | Substrate specificity and inhibitor analyses of human steroid 5β-reductase (AKR1D1). | Steroids | 2011 | https://conductscience.org/library/papers/21255593 | PubMed |
| 7 | 22876234 | Aldo-Keto Reductases 1B in Endocrinology and Metabolism. | Front Pharmacol | 2012 | https://conductscience.org/library/papers/22876234 | PubMed |
| 8 | 27716796 | Functional Trade-Offs in Promiscuous Enzymes Cannot Be Explained by Intrinsic Mutational Robustness of the Native Activity. | PLoS Genet | 2016 | https://conductscience.org/library/papers/27716796 | PubMed |
| 9 | 15492289 | Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling. | Cancer Res | 2004 | https://conductscience.org/library/papers/15492289 | PubMed |
| 10 | 29075254 | Babesia microti Aldo-keto Reductase-Like Protein Involved in Antioxidant and Anti-parasite Response. | Front Microbiol | 2017 | https://conductscience.org/library/papers/29075254 | PubMed |
| 11 | 20628518 | Aldo-keto reductases in the eye. | J Ophthalmol | 2010 | https://conductscience.org/library/papers/20628518 | PubMed |
| 12 | 15642094 | Computational prediction of human metabolic pathways from the complete human genome. | Genome Biol | 2005 | https://conductscience.org/library/papers/15642094 | PubMed |
| 13 | 24917395 | Aldo-keto reductase 1C3 is overexpressed in skin squamous cell carcinoma (SCC) and affects SCC growth via prostaglandin metabolism. | Exp Dermatol | 2014 | https://conductscience.org/library/papers/24917395 | PubMed |
| 14 | 25686905 | Acquisition of doxorubicin resistance facilitates migrating and invasive potentials of gastric cancer MKN45 cells through up-regulating aldo-keto reductase 1B10. | Chem Biol Interact | 2015 | https://conductscience.org/library/papers/25686905 | PubMed |
| 15 | 28124606 | Cytochrome P450 Structure, Function and Clinical Significance: A Review. | Curr Drug Targets | 2018 | https://conductscience.org/library/papers/28124606 | PubMed |
| 16 | 37335080 | A curated list of targeted optimized promiscuous ketoreductases (TOP-K). | Biochem J | 2023 | https://conductscience.org/library/papers/37335080 | PubMed |
| 17 | 18616992 | Inactivation of the anticancer drugs doxorubicin and oracin by aldo-keto reductase (AKR) 1C3. | Toxicol Lett | 2008 | https://conductscience.org/library/papers/18616992 | PubMed |
| 18 | 19011751 | Medium- and short-chain dehydrogenase/reductase gene and protein families : the MDR superfamily. | Cell Mol Life Sci | 2008 | https://conductscience.org/library/papers/19011751 | PubMed |
| 19 | 24571686 | AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression. | Diagn Pathol | 2014 | https://conductscience.org/library/papers/24571686 | PubMed |
| 20 | 34063865 | The Role of AKR1B10 in Physiology and Pathophysiology. | Metabolites | 2021 | https://conductscience.org/library/papers/34063865 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41246341 | Lactylation-related gene AKR1A1 contributes to osteoporosis via metabolic-immune regulation: evidence from multi-omics integration, single-cell transcriptomics, and in vitro validation. | Front Immunol | 2025 | https://conductscience.org/library/papers/41246341 | PubMed |
| 41154825 | Aldose Reductase Involvement in EMT: Emerging Insights and Current Proposed Molecular Mechanisms. | Biology (Basel) | 2025 | https://conductscience.org/library/papers/41154825 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38947111
GET https://conductscience.org/api/papers/v1/38947111/references?page=2